Netherlands Biotechnology & Medical Research

Pharvaris N.V. (PHVS)

Pharvaris N.V. experienced significant selling activity recently, with insiders offloading over 5 million dollars in net value. Thirty-seven transactions occurred, primarily involving directors and executives. This trend follows an August earnings report that missed expectations. Stock performance remains relatively stable despite these divestments, reflecting a cautious sentiment among key leadership personnel regarding current equity valuations.
Ticker: PHVS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pharvaris N.V.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Monges Viviane Non-Executive Director
Transaction date
Sale
Price
229.38
Quantity 51,132 -32.0%
Value US$2,749,252
2.2
VIVIANE ROSINE FRANCOISE BECK MONGES Director Non-Executive Director
Transaction date
Proposed sale
Price
104.37
Quantity 69,919
Value US$1,456,948
JOHANNES GER. CHRIS. PE SCHIKAN Director Non-Executive Director
Transaction date
Proposed sale
Price
36.19
Quantity 800
Value US$28,952
1.2
Nassif David W. CFO / CLO Officer
Transaction date
Sale
Price
36.47
Quantity 6,000 -5.0%
Value US$218,801
1.2
DAVID NASSIF Officer Officer
Transaction date
Proposed sale
Price
36.47
Quantity 6,000
Value US$218,801
Lu Peng President Officer
Transaction date
Sale
Price
35.00
Quantity 100,000 -60.6%
Value US$3,500,000
0.7
Glassman Robert Non-Executive Director
Transaction date
Planned sale
Price
38.56
Quantity 14,493 -58.0%
Value US$558,812
3.0
Bjork Elisabeth Non-Executive Director
Transaction date
Sale
Price
37.89
Quantity 52,500 -77.6%
Value US$1,989,409
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Sale
Price
38.27
Quantity 20,000 -21.3%
Value US$765,466
PENG LU Officer Officer
Transaction date
Proposed sale
Price
35.00
Quantity 100,000
Value US$3,500,000
SCHOODIC MANAGEMENT BV Officer; Director Executive Director
Transaction date
Proposed sale
Price
35.00
Quantity 300,000
Value US$10,500,000
JOHANNES GER. CHRIS. PE SCHIKAN Officer; Director Executive Director
Transaction date
Proposed sale
Price
35.00
Quantity 200,000
Value US$7,000,000
3.0
ELISABETH E. BJORK Director Non-Executive Director
Transaction date
Proposed sale
Price
37.89
Quantity 52,500
Value US$1,989,409
2.0
GRAYMATTERS CONSULTING Officer Officer
Transaction date
Proposed sale
Price
38.27
Quantity 20,000
Value US$765,466
0.7
ROBERT GLASSMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
38.56
Quantity 14,493
Value US$558,812
1.6
Abele Stefan Andreas Chief Technical Ops Officer Officer
Transaction date
Sale
Price
39.24
Quantity 1,400 -3.5%
Value US$54,938
1.6
Abele Stefan Andreas Chief Technical Ops Officer Officer
Transaction date
Sale
Price
38.14
Quantity 45,000 -52.7%
Value US$1,716,188
0.7
Glassman Robert Non-Executive Director
Transaction date
Planned sale
Price
38.27
Quantity 8,667 -45.2%
Value US$331,716
Souverijns Wim Chief Commercial Officer Officer
Transaction date
Planned sale
Price
38.99
Quantity 6,090 -13.5%
Value US$237,449
1.6
STEFAN ABELE Officer Officer
Transaction date
Proposed sale
Price
38.17
Quantity 46,400
Value US$1,771,125
0.7
ROBERT GLASSMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
38.27
Quantity 8,667
Value US$331,716
Souverijns Wim Chief Commercial Officer Officer
Transaction date
Planned sale
Price
39.31
Quantity 20,000 -30.7%
Value US$786,126
Modig Berndt Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
39.40
Quantity 2,291 -1.8%
Value US$90,276
WIM SOUVERIJNS Officer Officer
Transaction date
Proposed sale
Price
39.23
Quantity 26,090
Value US$1,023,583
Berndt B.A,E. Modig Director; Officer Executive Director
Transaction date
Proposed sale
Price
38.02
Quantity 2,291
Value US$87,104
Lu Peng President Officer
Transaction date
Planned sale
Price
40.13
Quantity 15,000 -18.7%
Value US$601,947
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
38.30
Quantity 30,000 -34.7%
Value US$1,149,084
2.0
ANNE LESAGE Officer Officer
Transaction date
Proposed sale
Price
38.30
Quantity 30,000
Value US$1,149,084
0.7
Glassman Robert Non-Executive Director
Transaction date
Planned sale
Price
37.55
Quantity 8,000 -43.2%
Value US$300,396
0.7
ROBERT R. GLASSMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
37.55
Quantity 8,000
Value US$300,396
Lu Peng President Officer
Transaction date
Planned sale
Price
40.68
Quantity 15,000 -18.7%
Value US$610,134
PENG LU Officer Officer
Transaction date
Proposed sale
Price
35.25
Quantity 30,000
Value US$1,057,500
Modig Berndt Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.77
Quantity 2,292 -1.7%
Value US$79,686
Berndt B.A,E. Modig Director; Officer Executive Director
Transaction date
Proposed sale
Price
34.04
Quantity 2,292
Value US$78,020
Modig Berndt Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.97
Quantity 2,292 -1.7%
Value US$80,154
Berndt B.A,E. Modig Director; Officer Executive Director
Transaction date
Proposed sale
Price
35.07
Quantity 2,292
Value US$80,380
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.49
Quantity 30,703 -24.6%
Value US$1,089,637
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.48
Quantity 27,872 -32.2%
Value US$988,890
2.0
GrayMatters Consulting B.V. Officer Officer
Transaction date
Proposed sale
Price
34.71
Quantity 30,703
Value US$1,065,701
2.0
ANNE SIMONNE J. LESAGE Officer Officer
Transaction date
Proposed sale
Price
34.71
Quantity 27,872
Value US$967,437
Hans H. Schikan Director Non-Executive Director
Transaction date
Proposed sale
Price
34.71
Quantity 30,712
Value US$1,066,014
Hans H. Schikan Director Non-Executive Director
Transaction date
Proposed sale
Price
34.71
Quantity 30,712
Value US$1,066,014
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.05
Quantity 6,997 -5.3%
Value US$245,232
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.05
Quantity 8,300 -12.4%
Value US$290,908
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.12
Quantity 2,300 -3.9%
Value US$80,786
Hans H. Schikan Director Non-Executive Director
Transaction date
Proposed sale
Price
34.01
Quantity 6,888
Value US$234,261
2.0
GrayMatters Consulting B.V. Officer Officer
Transaction date
Proposed sale
Price
34.01
Quantity 6,997
Value US$237,968
2.0
ANNE SIMONNE J. LESAGE Officer Officer
Transaction date
Proposed sale
Price
34.01
Quantity 8,300
Value US$282,283
Lu Peng Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.00
Quantity 14,700 -18.3%
Value US$499,847
PENG LU Officer Officer
Transaction date
Proposed sale
Price
33.30
Quantity 14,700
Value US$489,510
PENG LU Officer Officer
Transaction date
Proposed sale
Price
33.30
Quantity 14,700
Value US$489,510
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.12
Quantity 2,300 -1.7%
Value US$80,786
2.0
Lesage Anne Chief Early Development Officer
Transaction date
Planned sale
Price
35.12
Quantity 2,300 -3.9%
Value US$80,775
Lu Peng Chief Medical Officer Officer
Transaction date
Planned sale
Price
35.09
Quantity 3,400 -4.9%
Value US$119,310
Lu Peng Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.45
Quantity 11,600 -14.4%
Value US$399,675
PENG LU Officer Officer
Transaction date
Proposed sale
Price
33.29
Quantity 15,000
Value US$499,350
2.0
ANNE SIMONNE J. LESAGE Officer Officer
Transaction date
Proposed sale
Price
33.29
Quantity 2,300
Value US$76,567
Hans H. Schikan Director Non-Executive Director
Transaction date
Proposed sale
Price
33.29
Quantity 2,400
Value US$79,896
2.0
GrayMatters Consulting B.V. Officer Officer
Transaction date
Proposed sale
Price
33.29
Quantity 2,300
Value US$76,567
Lu Peng Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.00
Quantity 300 -0.5%
Value US$10,200
PENG LU Officer Officer
Transaction date
Proposed sale
Price
33.41
Quantity 300
Value US$10,023
Modig Berndt Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
31.46
Quantity 100 -0.1%
Value US$3,146
Modig Berndt Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
31.05
Quantity 2,191 -1.6%
Value US$68,027
Berndt B.A.E. Modig Director; Officer Executive Director
Transaction date
Proposed sale
Price
30.72
Quantity 2,291
Value US$70,380
1.1
Nijdam Anna Principal Accounting Officer Officer
Transaction date
Sale
Price
30.87
Quantity 2,670 -5.5%
Value US$82,425
1.1
ANNA NIJDAM Officer Officer
Transaction date
Proposed sale
Price
30.87
Quantity 2,670
Value US$82,425
1.1
Nijdam Anna Principal Accounting Officer Officer
Transaction date
Sale
Price
30.74
Quantity 5,501 -10.1%
Value US$169,084
1.1
ANNA NIJDAM Officer Officer
Transaction date
Proposed sale
Price
30.74
Quantity 5,501
Value US$169,084
2.2
Monges Viviane Non-Executive Director
Transaction date
Sale
Price
30.29
Quantity 9,667 -63.7%
Value US$292,853
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-25 2026-09-23 S Sale
2.2
Monges Viviane
Non-Executive Director
51,132 -32.0%
229.38
US$2,749,252 		51,132 -32.0% 229.38 US$2,749,252
2026-09-23 2026-09-23 PrS Proposed sale
2.2
VIVIANE ROSINE FRANCOISE BECK MONGES

Director

Non-Executive Director
69,919
104.37
US$1,456,948 		69,919 104.37 US$1,456,948
2026-09-24 2026-09-22 S Sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
24,010 +19.9%
34.49
US$3,960,495 		24,010 +19.9% 34.49 US$3,960,495
2026-09-22 2026-09-22 PrS Proposed sale
JOHANNES GER. CHRIS. PE SCHIKAN

Director

Non-Executive Director
800
36.19
US$28,952 		800 36.19 US$28,952
2026-09-23 2026-09-21 S Sale
1.2
Nassif David W.

CFO / CLO

Officer
6,000 -5.0%
36.47
US$218,801 		6,000 -5.0% 36.47 US$218,801
2026-09-21 2026-09-21 PrS Proposed sale
1.2
DAVID NASSIF

Officer

Officer
6,000
36.47
US$218,801 		6,000 36.47 US$218,801
2026-09-22 2026-09-17 PrS Proposed sale
JOHANNES GER. CHRIS. PE SCHIKAN

Officer; Director

Executive Director
200,000
35.00
US$7,000,000 		200,000 35.00 US$7,000,000
2026-09-21 2026-09-17 S Sale
Lu Peng

President

Officer
100,000 -60.6%
35.00
US$3,500,000 		100,000 -60.6% 35.00 US$3,500,000
2026-09-21 2026-09-17 S Sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
200,000 -63.5%
35.00
US$7,000,000 		200,000 -63.5% 35.00 US$7,000,000
2026-09-21 2026-09-17 PlS Planned sale
0.7
Glassman Robert
Non-Executive Director
14,493 -58.0%
38.56
US$558,812 		14,493 -58.0% 38.56 US$558,812
2026-09-21 2026-09-17 S Sale
3.0
Bjork Elisabeth
Non-Executive Director
52,500 -77.6%
37.89
US$1,989,409 		52,500 -77.6% 37.89 US$1,989,409
2026-09-21 2026-09-17 S Sale
2.0
Lesage Anne

Chief Early Development

Officer
20,000 -21.3%
38.27
US$765,466 		20,000 -21.3% 38.27 US$765,466
2026-09-17 2026-09-17 PrS Proposed sale
PENG LU

Officer

Officer
100,000
35.00
US$3,500,000 		100,000 35.00 US$3,500,000
2026-09-17 2026-09-17 PrS Proposed sale
SCHOODIC MANAGEMENT BV

Officer; Director

Executive Director
300,000
35.00
US$10,500,000 		300,000 35.00 US$10,500,000
2026-09-17 2026-09-17 PrS Proposed sale
JOHANNES GER. CHRIS. PE SCHIKAN

Officer; Director

Executive Director
200,000
35.00
US$7,000,000 		200,000 35.00 US$7,000,000
2026-09-17 2026-09-17 PrS Proposed sale
3.0
ELISABETH E. BJORK

Director

Non-Executive Director
52,500
37.89
US$1,989,409 		52,500 37.89 US$1,989,409
2026-09-17 2026-09-17 PrS Proposed sale
2.0
GRAYMATTERS CONSULTING

Officer

Officer
20,000
38.27
US$765,466 		20,000 38.27 US$765,466
2026-09-17 2026-09-17 PrS Proposed sale
0.7
ROBERT GLASSMAN

Director

Non-Executive Director
14,493
38.56
US$558,812 		14,493 38.56 US$558,812
2026-09-17 2026-09-15 S Sale
1.6
Abele Stefan Andreas

Chief Technical Ops Officer

Officer
1,400 -3.5%
39.24
US$54,938 		1,400 -3.5% 39.24 US$54,938
2026-09-17 2026-09-15 S Sale
1.6
Abele Stefan Andreas

Chief Technical Ops Officer

Officer
45,000 -52.7%
38.14
US$1,716,188 		45,000 -52.7% 38.14 US$1,716,188
2026-09-17 2026-09-15 PlS Planned sale
0.7
Glassman Robert
Non-Executive Director
8,667 -45.2%
38.27
US$331,716 		8,667 -45.2% 38.27 US$331,716
2026-09-16 2026-09-15 PlS Planned sale
Souverijns Wim

Chief Commercial Officer

Officer
6,090 -13.5%
38.99
US$237,449 		6,090 -13.5% 38.99 US$237,449
2026-09-15 2026-09-15 PrS Proposed sale
1.6
STEFAN ABELE

Officer

Officer
46,400
38.17
US$1,771,125 		46,400 38.17 US$1,771,125
2026-09-15 2026-09-15 PrS Proposed sale
0.7
ROBERT GLASSMAN

Director

Non-Executive Director
8,667
38.27
US$331,716 		8,667 38.27 US$331,716
2026-09-16 2026-09-14 PlS Planned sale
Souverijns Wim

Chief Commercial Officer

Officer
20,000 -30.7%
39.31
US$786,126 		20,000 -30.7% 39.31 US$786,126
2026-09-15 2026-09-14 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
2,291 -1.8%
39.40
US$90,276 		2,291 -1.8% 39.40 US$90,276
2026-09-14 2026-09-14 PrS Proposed sale
WIM SOUVERIJNS

Officer

Officer
26,090
39.23
US$1,023,583 		26,090 39.23 US$1,023,583
2026-09-14 2026-09-14 PrS Proposed sale
Berndt B.A,E. Modig

Director; Officer

Executive Director
2,291
38.02
US$87,104 		2,291 38.02 US$87,104
2026-09-15 2026-09-11 PlS Planned sale
Lu Peng

President

Officer
15,000 -18.7%
40.13
US$601,947 		15,000 -18.7% 40.13 US$601,947
2026-09-14 2026-09-10 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
30,000 -34.7%
38.30
US$1,149,084 		30,000 -34.7% 38.30 US$1,149,084
2026-09-10 2026-09-10 PrS Proposed sale
2.0
ANNE LESAGE

Officer

Officer
30,000
38.30
US$1,149,084 		30,000 38.30 US$1,149,084
2026-09-11 2026-09-09 PlS Planned sale
0.7
Glassman Robert
Non-Executive Director
8,000 -43.2%
37.55
US$300,396 		8,000 -43.2% 37.55 US$300,396
2026-09-09 2026-09-09 PrS Proposed sale
0.7
ROBERT R. GLASSMAN

Director

Non-Executive Director
8,000
37.55
US$300,396 		8,000 37.55 US$300,396
2026-09-09 2026-09-08 PlS Planned sale
Lu Peng

President

Officer
15,000 -18.7%
40.68
US$610,134 		15,000 -18.7% 40.68 US$610,134
2026-09-08 2026-09-08 PrS Proposed sale
PENG LU

Officer

Officer
30,000
35.25
US$1,057,500 		30,000 35.25 US$1,057,500
2026-08-18 2026-08-14 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
2,292 -1.7%
34.77
US$79,686 		2,292 -1.7% 34.77 US$79,686
2026-08-14 2026-08-14 PrS Proposed sale
Berndt B.A,E. Modig

Director; Officer

Executive Director
2,292
34.04
US$78,020 		2,292 34.04 US$78,020
2026-07-15 2026-07-13 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
2,292 -1.7%
34.97
US$80,154 		2,292 -1.7% 34.97 US$80,154
2026-07-13 2026-07-13 PrS Proposed sale
Berndt B.A,E. Modig

Director; Officer

Executive Director
2,292
35.07
US$80,380 		2,292 35.07 US$80,380
2026-07-01 2026-06-30 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
30,712 -8.9%
35.49
US$1,090,049 		30,712 -8.9% 35.49 US$1,090,049
2026-07-01 2026-06-30 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
30,703 -24.6%
35.49
US$1,089,637 		30,703 -24.6% 35.49 US$1,089,637
2026-07-01 2026-06-30 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
27,872 -32.2%
35.48
US$988,890 		27,872 -32.2% 35.48 US$988,890
2026-06-30 2026-06-30 PrS Proposed sale
2.0
GrayMatters Consulting B.V.

Officer

Officer
30,703
34.71
US$1,065,701 		30,703 34.71 US$1,065,701
2026-06-30 2026-06-30 PrS Proposed sale
2.0
ANNE SIMONNE J. LESAGE

Officer

Officer
27,872
34.71
US$967,437 		27,872 34.71 US$967,437
2026-06-30 2026-06-30 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
30,712
34.71
US$1,066,014 		30,712 34.71 US$1,066,014
2026-06-30 2026-06-30 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
30,712
34.71
US$1,066,014 		30,712 34.71 US$1,066,014
2026-07-01 2026-06-29 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
6,888 -2.0%
35.05
US$241,447 		6,888 -2.0% 35.05 US$241,447
2026-07-01 2026-06-29 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
6,997 -5.3%
35.05
US$245,232 		6,997 -5.3% 35.05 US$245,232
2026-07-01 2026-06-29 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
8,300 -12.4%
35.05
US$290,908 		8,300 -12.4% 35.05 US$290,908
2026-07-01 2026-06-29 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
2,300 -3.9%
35.12
US$80,786 		2,300 -3.9% 35.12 US$80,786
2026-06-29 2026-06-29 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
2,400 -0.7%
35.10
US$84,250 		2,400 -0.7% 35.10 US$84,250
2026-06-29 2026-06-29 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
6,888
34.01
US$234,261 		6,888 34.01 US$234,261
2026-06-29 2026-06-29 PrS Proposed sale
2.0
GrayMatters Consulting B.V.

Officer

Officer
6,997
34.01
US$237,968 		6,997 34.01 US$237,968
2026-06-29 2026-06-29 PrS Proposed sale
2.0
ANNE SIMONNE J. LESAGE

Officer

Officer
8,300
34.01
US$282,283 		8,300 34.01 US$282,283
2026-06-29 2026-06-26 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
14,700 -18.3%
34.00
US$499,847 		14,700 -18.3% 34.00 US$499,847
2026-06-26 2026-06-26 PrS Proposed sale
PENG LU

Officer

Officer
14,700
33.30
US$489,510 		14,700 33.30 US$489,510
2026-06-26 2026-06-26 PrS Proposed sale
PENG LU

Officer

Officer
14,700
33.30
US$489,510 		14,700 33.30 US$489,510
2026-06-29 2026-06-25 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
2,300 -1.7%
35.12
US$80,786 		2,300 -1.7% 35.12 US$80,786
2026-06-29 2026-06-25 PlS Planned sale
2.0
Lesage Anne

Chief Early Development

Officer
2,300 -3.9%
35.12
US$80,775 		2,300 -3.9% 35.12 US$80,775
2026-06-29 2026-06-25 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
3,400 -4.9%
35.09
US$119,310 		3,400 -4.9% 35.09 US$119,310
2026-06-29 2026-06-25 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
11,600 -14.4%
34.45
US$399,675 		11,600 -14.4% 34.45 US$399,675
2026-06-25 2026-06-25 PrS Proposed sale
PENG LU

Officer

Officer
15,000
33.29
US$499,350 		15,000 33.29 US$499,350
2026-06-25 2026-06-25 PrS Proposed sale
2.0
ANNE SIMONNE J. LESAGE

Officer

Officer
2,300
33.29
US$76,567 		2,300 33.29 US$76,567
2026-06-25 2026-06-25 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
2,400
33.29
US$79,896 		2,400 33.29 US$79,896
2026-06-25 2026-06-25 PrS Proposed sale
2.0
GrayMatters Consulting B.V.

Officer

Officer
2,300
33.29
US$76,567 		2,300 33.29 US$76,567
2026-06-23 2026-06-18 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
300 -0.5%
34.00
US$10,200 		300 -0.5% 34.00 US$10,200
2026-06-18 2026-06-18 PrS Proposed sale
PENG LU

Officer

Officer
300
33.41
US$10,023 		300 33.41 US$10,023
2026-06-17 2026-06-15 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
100 -0.1%
31.46
US$3,146 		100 -0.1% 31.46 US$3,146
2026-06-17 2026-06-15 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
2,191 -1.6%
31.05
US$68,027 		2,191 -1.6% 31.05 US$68,027
2026-06-15 2026-06-15 PrS Proposed sale
Berndt B.A.E. Modig

Director; Officer

Executive Director
2,291
30.72
US$70,380 		2,291 30.72 US$70,380
2026-06-08 2026-06-04 S Sale
1.1
Nijdam Anna

Principal Accounting Officer

Officer
2,670 -5.5%
30.87
US$82,425 		2,670 -5.5% 30.87 US$82,425
2026-06-04 2026-06-04 PrS Proposed sale
1.1
ANNA NIJDAM

Officer

Officer
2,670
30.87
US$82,425 		2,670 30.87 US$82,425
2026-05-26 2026-05-22 S Sale
1.1
Nijdam Anna

Principal Accounting Officer

Officer
5,501 -10.1%
30.74
US$169,084 		5,501 -10.1% 30.74 US$169,084
2026-05-22 2026-05-22 PrS Proposed sale
1.1
ANNA NIJDAM

Officer

Officer
5,501
30.74
US$169,084 		5,501 30.74 US$169,084
2026-05-26 2026-05-21 S Sale
2.2
Monges Viviane
Non-Executive Director
9,667 -63.7%
30.29
US$292,853 		9,667 -63.7% 30.29 US$292,853

See older Pharvaris N.V. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Pharvaris N.V. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Pharvaris N.V.

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe